What did @cristina.noh actually say?
The creator walks 286,000 viewers through reconstituting an unspecified injectable peptide she calls a 'glow peptide stack,' using bacteriostatic water she sourced from Amazon, insulin syringes, and alcohol swabs. She describes injecting 3 mL of bacteriostatic water into a lyophilized vial, drawing 20 units daily into a subcutaneous injection site, and purchasing the product through someone on Facebook who 'sends it to you as a package' and is 'available for a call.' She notes a burning sensation post-injection and massages the site afterward. At no point does she name the specific peptide compounds in the stack, disclose lab testing results, or mention a prescribing physician.
The video is framed as peer-to-peer guidance, not a medical demonstration. That framing matters, because what she's actually showing is how to self-administer an uncharacterized injectable compound purchased through an unregulated social media channel.
Does the science back this up?
Some of the individual peptides commonly marketed in 'glow stacks,' such as GHK-Cu, BPC-157, and TB-500, do have legitimate research behind them, but almost none of it involves human clinical trials at commercially available doses. The leap from 'this peptide has interesting cell culture data' to 'inject 20 units daily into your abdomen' is enormous.
GHK-Cu has shown wound-healing and collagen-stimulating activity in vitro (Pickart et al., 2015, Journal of Aging Research), but human dosing data is essentially nonexistent in peer-reviewed literature. BPC-157 has shown regenerative effects in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design), but no completed human RCTs exist. TB-500, a synthetic fragment of thymosin beta-4, has early-phase interest in cardiac repair but again, no approved human dosing protocol. The honest summary: the science is preliminary, mostly preclinical, and does not support confident dosing instructions delivered over TikTok.
What did they get wrong (or right)?
Credit where it's due: injecting bacteriostatic water gently along the vial wall to avoid peptide degradation is textbook reconstitution practice. Peptides, particularly those with disulfide bonds, can denature under mechanical stress or direct stream pressure. That part she got right.
What she got wrong is harder to ignore. Sourcing injectables through a Facebook seller is not a minor procedural quirk. It means no Certificate of Analysis, no sterility testing, no endotoxin screening, and no chain of custody. The FDA has explicitly warned that compounded peptides purchased outside licensed pharmacy channels carry contamination and mislabeling risks (FDA, 2023 guidance on outsourced facilities). Recommending people massage an injection site post-injection also runs counter to standard subcutaneous injection practice, which advises against rubbing to prevent tissue irritation and altered absorption. And describing dosing as '20 units daily' for '8 to 10 weeks' without any individualization is precisely the kind of blanket instruction that causes harm at scale.
What should you actually know?
If you're interested in peptide therapy, the access pathway matters as much as the compound itself. Legitimate peptide prescriptions in the U.S. go through a licensed provider, are dispensed by an FDA-registered 503A or 503B compounding pharmacy, and come with documented sterility testing. Anything sourced through social media, regardless of how confident the seller sounds, bypasses every one of those safeguards.
The burning sensation the creator describes post-injection can be normal with subcutaneous peptide administration, but it can also signal pH issues, contamination, or injection technique problems. Without knowing what's actually in the vial, there's no way to distinguish between those possibilities. The FDA's MedWatch program has received adverse event reports tied to unverified compounded injectables, including abscesses and systemic reactions. At 286,000 views, this video is a dosing tutorial for a product of unknown composition, distributed through an unlicensed channel, to an audience with no clinical oversight. That combination deserves skepticism, not a swirl and a 45-degree angle.